Drug distributor McKesson Corp raised its annual profit forecast on Wednesday, driven by increased sales in its U.S.
Operator Ladies and gentlemen, welcome to McKesson's second quarter fiscal 2025 earnings conference call. Please be advised that today's conference is being recorded. At this time, I'd like to turn ...
Nov. 4 (UPI) --McKesson Medical-Surgical Inc. entered into an agreement with the Labor Department on Monday resolving ...
Although the revenue and EPS for McKesson (MCK) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall ...
MCK's second-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment, driven by higher prescription volume.
IRVING, Texas (AP) — IRVING, Texas (AP) — McKesson Corp. (MCK) on Wednesday reported fiscal second-quarter net income of $241 million. The Irving, Texas-based company said it had net income of $1.87 ...
Elizabeth Warren seeks scrutiny of deals that would allow drug middlemen McKesson, Cardinal Health, and Cencora to also ...
Sen. Elizabeth Warren calls on FTC to block medical distributors McKesson (MCK) and Cardinal Health's (MCK) recent deals to ...
In terms of liquidity and interest, the mean open interest for McKesson options trades today is 166.17 with a total volume of ...
McKesson Corporation (NYSE: MCK) has released its fiscal 2025 second quarter financial results. Results can be accessed on ...